# OnCo record fs-207 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fs-207/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fs-207" ;
  schema:name "FS-207"@en ;
  schema:description "FS-207 is an experimental oral small molecule from Fushi Biotechnology, in phase 1 trials for MSI-high advanced solid tumours."@en ;
  schema:url <https://onco.cc/drugs/fs-207/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.foresightbiopharm.com/en/pipeline.html>, <https://www.foresightbiopharm.com/>, <https://clinicaltrials.gov/api/v2/studies/NCT07593144>, <https://clinicaltrials.gov/search?intr=FS-207> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral small molecule (tablet)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/wrn/> ;
  onco:companies <https://onco.cc/companies/fushi-biotechnology/> ;
  onco:trials <https://onco.cc/trials/nct07593144/> .